Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph D Jackson

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 16, 2010
Economic evaluations alongside effectiveness trialsJoseph D Jackson
American Health & Drug Benefits|September 20, 2014
Population health and the assessment of valueJoseph D Jackson
The American Journal of Managed Care|July 18, 2003
Allocating funds for cardiovascular disease prevention in light of the NCEP ATP III guidelinesJaime Caro, Krista F Huybrechts, Wendy S Klittich, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 13, 2007
Patient-reported outcome instrument selection: designing a measurement strategyClaire F Snyder, Maria E Watson, Joseph D Jackson, et al.
American Journal of Therapeutics|September 12, 2012
Perceived or actual barriers to warfarin use in atrial fibrillation based on electronic medical recordsMarc B Rosenman, Teresa A Simon, Evgenia Teal, et al.
Journal of the American Board of Family Medicine : JABFM|March 15, 2018
Evaluation of an Ongoing Diabetes Group Medical Visit in a Family Medicine PracticeAmy T Cunningham, David J Delgado, Joseph D Jackson, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|June 6, 2006
Assessing health state utilities in elderly patients at cardiovascular riskWolfgang C Winkelmayer, Joshua S Benner, Robert J Glynn, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 4, 2009
Cost-effectiveness of clopidogrel plus aspirin versus aspirin alone for secondary prevention of cardiovascular events: results from the CHARISMA trialJersey Chen, Deepak L Bhatt, Elizabeth Schneider Dunn, et al.
Circulation. Cardiovascular Quality and Outcomes|December 25, 2009
One-year costs in patients with a history of or at risk for atherothrombosis in the United StatesElizabeth M Mahoney, Kaijun Wang, David J Cohen, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 16, 2010
Economic evaluations alongside effectiveness trialsJoseph D Jackson
American Health & Drug Benefits|September 20, 2014
Population health and the assessment of valueJoseph D Jackson
The American Journal of Managed Care|July 18, 2003
Allocating funds for cardiovascular disease prevention in light of the NCEP ATP III guidelinesJaime Caro, Krista F Huybrechts, Wendy S Klittich, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 13, 2007
Patient-reported outcome instrument selection: designing a measurement strategyClaire F Snyder, Maria E Watson, Joseph D Jackson, et al.
American Journal of Therapeutics|September 12, 2012
Perceived or actual barriers to warfarin use in atrial fibrillation based on electronic medical recordsMarc B Rosenman, Teresa A Simon, Evgenia Teal, et al.
Journal of the American Board of Family Medicine : JABFM|March 15, 2018
Evaluation of an Ongoing Diabetes Group Medical Visit in a Family Medicine PracticeAmy T Cunningham, David J Delgado, Joseph D Jackson, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|June 6, 2006
Assessing health state utilities in elderly patients at cardiovascular riskWolfgang C Winkelmayer, Joshua S Benner, Robert J Glynn, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 4, 2009
Cost-effectiveness of clopidogrel plus aspirin versus aspirin alone for secondary prevention of cardiovascular events: results from the CHARISMA trialJersey Chen, Deepak L Bhatt, Elizabeth Schneider Dunn, et al.
Circulation. Cardiovascular Quality and Outcomes|December 25, 2009
One-year costs in patients with a history of or at risk for atherothrombosis in the United StatesElizabeth M Mahoney, Kaijun Wang, David J Cohen, et al.
Pageof 1